US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia

NCT04103879 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

ExCellThera inc.

Collaborators